Piramal Pharma Limited (PPLPHARMA) — Cash Flow Quality Index
Piramal Pharma Limited (PPLPHARMA) has a Cash Flow Quality Index of 36.86x as of December 2023. Operating cash flow of Rs3.73 Billion exceeds net income of Rs101.10 Million, indicating high earnings quality where cash backs reported profits. Also explore Piramal Pharma Limited total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Piramal Pharma Limited Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for Piramal Pharma Limited across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check PPLPHARMA intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Piramal Pharma Limited (2021–2025)
Year-by-year earnings quality comparison for Piramal Pharma Limited. For live market cap and the full company financial profile, see market cap of Piramal Pharma Limited.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 9.79x | Rs8.92 Billion | Rs911.30 Million | ▼ -82.6% |
| 2024 | 56.37x | Rs10.05 Billion | Rs178.20 Million | ▲ +9546.3% |
| 2022 | 0.58x | Rs2.55 Billion | Rs4.37 Billion | ▲ +487.6% |
| 2021 | 0.10x | Rs347.20 Million | Rs3.49 Billion | — |